TokenPost·

Regeneron and Alnylam Win FDA Approval for Livsayis in Adults

Your call?

The RNA therapeutic, identified as Livsayis (cemdisiran), was approved to treat adults with myasthenia gravis, a chronic autoimmune condition.

Share

More news